Peptides for Endurance Training Research

Endurance peptide research examines compounds targeting mitochondrial function, metabolic flexibility, and aerobic capacity. MOTS-c is studied for mitochondrial-derived peptide signalling and metabolic regulation. GH secretagogues are investigated for effects on lactate clearance and oxidative metabolism. Metabolic modulators are explored for glucose handling and fuel substrate switching in aerobic contexts.

MOTS-c research demonstrates mitochondrial biogenesis in animal models and improvements in glucose tolerance. GH secretagogue studies show improvements in aerobic parameters in GH-deficient populations, with less clear evidence in trained endurance athletes. Limited human data exists on direct endurance performance metrics with peptide intervention.

Endurance-specific peptide research is sparse in human populations. Most mitochondrial data come from metabolic disease models rather than athletic adaptation. No large trials directly measure VO2 max or endurance performance gains with peptide intervention. Long-term training response in athletes remains understudied.

Endurance performance peptides have no ARTG listing. Research-grade supply is legal for institutional use; personal application falls outside TGA frameworks. Medical practitioners cannot prescribe peptides for endurance enhancement without a registered medical condition warrant.